We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Alliance to Develop Molecular Imaging Techniques

By HospiMedica staff writers
Posted on 17 Sep 2002
A collaboration to undertake development of molecular imaging techniques for use in ultrasound, magnetic resonance, and nuclear medicine has been announced by Philips Medical Systems (Best, The Netherlands) and Kereos (St.Louis, MO, USA).

The collaboration will focus on image-based characterization of the molecular causes of diseases and will combine Kereos' targeted nanoparticle technology with Philips' engineering, software development, and equipment support. The goal is to facilitate development of molecular imaging agents for specific and sensitive detection of tumors and vulnerable plaque in arteries, a major cause of heart disease. The leader of the project is Dr. Samuel A. Wickline, M.D., professor of medicine, biomedical engineering, and physics at Washington University School of Medicine in St. Louis (MO, USA).

"Our team is very excited about this agreement,” said Dr. Wickline. "We are certain that it will quickly lead to major breakthroughs in advancing contrast agent and scanner technology for molecular imaging and targeted therapeutics.”





Related Links:
Philips Medical Systems
Kereos
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Vessel Sealing Instrument
ERGOseal
Gas Analyzer
GE SAM

Channels

Artificial Intelligence

view channel
Image: Coredio’s CPSE is a a software-as-a-medical-device platform designed for use with consumer smartwatches and standard blood pressure cuffs in clinical and home settings under physician supervision (Photo courtesy of Coredio)

AI Platform Supports Noninvasive Remote Hemodynamic Monitoring in Heart Failure

Heart failure remains a leading cause of hospitalization in adults over 65, affecting more than 6.7 million people in the U.S. Clinicians often lose visibility into hemodynamic deterioration once patients... Read more